During the past decade, Cherry Health conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cherry Health" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Biogen" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cherry Health" #1 collaborator was "Takeda" with 2 trials as a collaborator, "Community Health Centers of Arkansas" with 1 trials as a collaborator, "Community Health Plan of Washington" with 1 trials as a collaborator, "HealthPartners Institute" with 1 trials as a collaborator and "Kaiser Permanente" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Cherry Health" are "Schizophrenia" (5 trials), "Bipolar Disorder" (1 trials), "Cognitive Impairment Associated With Schizophrenia" (1 trials), "Negative Symptoms" (1 trials) and "PTSD" (1 trials). Many other conditions were trialed in "Cherry Health" in a lesser frequency.

Most popular intervention types in "Cherry Health" are "Drug" (7 trials), "Other" (5 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ad26.COV2.S" (2 trials), "ASP4345" (1 trials), "BI 409306" (1 trials) and "BI 425809" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cherry Health" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Cherry Health". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Cherry Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cherry Health, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".